Gaucher Disease Types I and III Responded Well to Substrate Reduction Therapy Using Eliglustat

Gaucher disease (GD) causes the accumulation of glucocerebrosides in various organs, resulting in hepatosplenomegaly, anemia, decreased platelet counts, and bone disorders. Glucosylsphingosine accumulates in the brain and causes central nervous system (CNS) disorders. GD can be classified into types...

Descripción completa

Detalles Bibliográficos
Autores principales: Harai, Nozomi, Ichijo, Masashi, Uchinuma, Hiroyuki, Hanihara, Mitsuto, Kawaguchi, Yoshihiko, Ichikawa, Daisuke, Tsuchiya, Kyoichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641180/
https://www.ncbi.nlm.nih.gov/pubmed/36889706
http://dx.doi.org/10.2169/internalmedicine.1425-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641180/
https://www.ncbi.nlm.nih.gov/pubmed/36889706
http://dx.doi.org/10.2169/internalmedicine.1425-22

Ejemplares similares